Adoptive cell therapy uses activated or/and engineered T cells or NK cells as living medications that are infused into patients to induce an antitumor immune response. The therapy relies on the body's
| Founded year: | Not set |
| Funding rounds: | Not set |
| Total funding amount: | Not set |